BioCardia Inc (NASDAQ:BCDA)

1.45
Delayed Data
As of Aug 05
 +0.01 / +0.69%
Today’s Change
1.10
Today|||52-Week Range
3.96
-25.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$26.7M

Company Description

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brands. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

Contact Information

BioCardia, Inc.
320 Soquel Way
Sunnyvale California 94085
P:(650) 226-0120
Investor Relations:
1650

Employees

Shareholders

Mutual fund holders7.59%
Individual stakeholders16.58%
Other institutional13.68%

Top Executives

Peter Alan AltmanPresident, Chief Executive Officer & Director
David McClungChief Financial Officer
Ian McNieceChief Scientific Officer
Sujith ShettyChief Medical Officer
Debby Holmes-HigginVice President-Clinical & Study Recruiting